Phreesia Inc
Q2 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +3.38%.
Did PHR Beat Earnings? Q2 2026 Results
Phreesia delivered a mixed fiscal second quarter for 2026, posting revenue of $117.25 million, up 14.8% year-over-year and edging past the $116.38 million consensus by 0.75%, while earnings came in far short of expectations, with GAAP diluted EPS of $0.01 against a consensus of $0.19, a miss of 94.81%. The earnings shortfall, however, obscures a meaningful underlying shift: Phreesia swung to GAAP net income of $654,000 from a net loss of $18.01 million a year ago, driven by sharply improving operating leverage and a discrete deferred tax benefit. Adjusted EBITDA more than tripled to $22.13 million from $6.53 million in Q2 FY2025, reflecting disciplined cost controls including a $4.80 million reduction in sales and marketing expense. The quarter's headline strategic move was Phreesia's announced $160 million cash acquisition of AccessOne, a healthcare financing platform expected to add roughly $35 million in annualized revenue and expand the company's total addressable market by approximately $6 billion. Looking ahead, management raised its FY2026 Adjusted EBITDA guidance to $87 million to $92 million while maintaining its revenue outlook of $472 million to $482 million, with at least one analyst lifting their price target following the results.
- 15% year-over-year total revenue growth driven by network solutions (25%), payment processing (12%) and subscription services (10%)
- 7% year-over-year growth in AHSCs to 4,467
- 7% year-over-year growth in total revenue per AHSC to $26,249
- 14% increase in patient payment volume year-over-year to $1.25 billion
- Operating leverage improvements across all expense categories, particularly sales and marketing expense declining $4.8 million year-over-year
- Discrete deferred tax benefit contributed to achieving first GAAP net income positive quarter
“I am proud to share that Phreesia has had many noteworthy developments over the past quarter. In addition to delivering another solid set of financial results, including achieving our first-ever net income positive quarter, we have expanded our reach and capabilities, positioning us well for the future. I am also excited to share that we entered into a definitive agreement to acquire AccessOne, a market leader in providing financing solutions for healthcare receivables.”
Phreesia CEO, on the earnings call
Forward Guidance & Outlook
Phreesia maintained its FY2026 revenue outlook of $472 million to $482 million, excluding any contribution from the AccessOne acquisition or other potential future acquisitions. The company raised its Adjusted EBITDA outlook to $87 million–$92 million from the previous range of $85 million–$90 million, reflecting continued improvements in operating leverage. AHSCs are expected to reach approximately 4,500 in FY2026, and total revenue per AHSC is expected to increase from FY2025 levels. The AccessOne acquisition is expected to contribute approximately $35 million in annualized revenue and $11 million in annualized Adjusted EBITDA. Phreesia expects to update its FY2026 outlook following the close of the AccessOne acquisition.
PHR YoY Financials
PHR Revenue by Segment
Figures from SEC filings and company reports. Not investment advice.